Another study demonstrated the level of serum squamous cell carcinoma antigen (SCC) increased in nonmalignant tumor disease including pneumonia, asthma, pulmonary tuberculosis, bronchiectasis, and interstitial pneumonia, with an average SCC-positive rate of 22.6% in bronchiectasis patients [14]. Here, SERPINB3 is linked to susceptibility to pneumonia measurement.